Soman Abraham

Dr. Soman Abraham

Department of Pathology, Duke University Medical Center (DUMC), Durham, NC 27710, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2010 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
Soman AbrahamSoman Abraham
Soman Abraham
AJAshley L. St. John
Ashley L. St. John

21 September 2015 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
Soman AbrahamSoman Abraham
Soman Abraham
YMYuxuan Miao
Yuxuan Miao

1 June 2015 in Cell
Verified
Journal Article
Closed access
YMYuxuan Miao
Yuxuan Miao
GLGuojie Li
Guojie Li
XZXiaoli Zhang
Xiaoli Zhang
HXHaoxing Xu
Haoxing Xu
Soman AbrahamSoman Abraham
Soman Abraham

8 April 2007 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
BBBrian L Bishop
Brian L Bishop
MDMathew J Duncan
Mathew J Duncan
JSJeongmin Song
Jeongmin Song
GLGuojie Li
Guojie Li
DZDavid Zaas
David Zaas
Soman AbrahamSoman Abraham
Soman Abraham

5 October 2009 in Journal of Experimental Medicine
Verified
Journal Article
Open access
CKChristian A. Kunder
Christian A. Kunder
AJAshley L. St. John
Ashley L. St. John
GLGuojie Li
Guojie Li
KLKam W Leong
Kam W Leong
BBBrent Berwin
Brent Berwin
Soman AbrahamSoman Abraham
Soman Abraham
During infection, signals from the periphery are known to reach draining lymph nodes (DLNs), but how these molecules, such as inflammatory cytokines, traverse the significant distances involved without dilution or degradation remains unclear. We show that peripheral mast cells, upon activation, release stable submicrometer heparin-based particles containing tumor necrosis factor and other proteins. These complexes enter lymphatic vessels and rapidly traffic to the DLNs. This physiological drug delivery system facilitates communication between peripheral sites of inflammation and remote secondary lymphoid tissues.

27 April 2007 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JSJeongmin Song
Jeongmin Song
MDMatthew J Duncan
Matthew J Duncan
GLGuojie Li
Guojie Li
CCCheryl Chan
Cheryl Chan
RGRichard Grady
Richard Grady
Soman AbrahamSoman Abraham
Soman Abraham
The vigorous cytokine response of immune cells to Gram-negative bacteria is primarily mediated by a recognition molecule, Toll-like receptor 4 (TLR4), which recognizes lipopolysaccharide (LPS) and initiates a series of intracellular NF-κB–associated signaling events. Recently, bladder epithelial cells (BECs) were reported to express TLR4 and to evoke a vigorous cytokine response upon exposure to LPS. We examined intracellular signaling events in human BECs leading to the production of IL-6, a major urinary cytokine, following activation by Escherichia coli and isolated LPS. We observed that in addition to the classical NF-κB–associated pathway, TLR4 triggers a distinct and more rapid signaling response involving, sequentially, Ca2+, adenylyl cyclase 3–generated cAMP, and a transcriptional factor, cAMP response element–binding protein. This capacity of BECs to mobilize secondary messengers and evoke a more rapid IL-6 response might be critical in their role as first responders to microbial challenge in the urinary tract. In spite of frequent cross contamination by bacteria from the gut, urinary tract infections are relatively infrequent. Although much of the credit goes to cells lining the urinary tract, such as bladder cells, how this is achieved remains unclear. Human bladder cells display, on their surfaces, special molecules called Toll-like receptors, which sense the presence of bacteria and trigger the cells to release a variety of chemicals called cytokines. Cytokines contribute to the recruitment of phagocytic cells from the blood to the site of infection to clear bacteria. In this paper, we reveal that the Toll-like receptor–initiated intracellular signals leading to the production of cytokines by bladder cells involve the same pathway seen in other cells, as well as an additional and more rapid signaling pathway. Rapid production of cytokines by bladder cells will facilitate early clearance of bacteria. Additionally, possession of multiple signaling pathways by bladder cells for producing cytokines is advantageous because bacteria that infect the urinary tract have the capability to suppress certain signaling events that lead to cytokine production by bladder cells.